Hims vs Ro for Weight Loss 2026: Which GLP-1 Provider Is Better?

What Is Hims Weight Loss?

Hims, officially Hims & Hers Health (NYSE: HIMS), launched in 2017 as a men's health telehealth platform and has since expanded into one of the largest direct-to-consumer health companies in the country. Their weight loss program, which gained significant traction through 2024 and 2025, prescribes compounded GLP-1 receptor agonists — primarily semaglutide — through an asynchronous telehealth consultation model.

The Hims workflow is straightforward: you complete an online health questionnaire, a licensed provider reviews your submission without a live conversation in most cases, and if clinically appropriate, a prescription is issued and filled through a partner compounding pharmacy. The medication ships directly to your door. Hims covers dozens of health categories beyond weight loss, including hair loss, erectile dysfunction, skincare, and mental health, making it a broad generalist platform.

Hims' key strengths are brand recognition, a polished user experience, and aggressive introductory pricing. Their limitations tend to center on provider specialization — with providers spread across many health categories — and pricing complexity that can make it hard to know your true monthly cost before committing.

What Is the Ro Weight Loss Program?

Ro, formerly known as Roman, started in 2017 with a focus on men's health and has evolved into a comprehensive telehealth platform with a dedicated weight management division called Ro Body. Unlike Hims' primarily asynchronous model, Ro emphasizes a more clinically integrated approach to weight loss, often including video consultations with providers and the option for metabolic lab work to guide treatment decisions.

Ro's weight loss program prescribes compounded semaglutide and, in some cases, compounded tirzepatide. Their model goes beyond simple medication delivery to include structured check-ins, provider-guided dose titration, and educational resources about nutrition and lifestyle modifications. Some Ro plans also include coaching components or integration with their broader health platform.

Ro's strengths include a more hands-on clinical approach, video consultations that allow for real-time conversation with providers, and a reputation for quality care. The trade-off is pricing — Ro tends to be more expensive than Hims and significantly more expensive than specialized compounded medication providers like Trimi.

Pricing Comparison: Hims vs Ro vs Trimi

Pricing is typically the first comparison patients make, and for good reason — GLP-1 treatment can last months or years, making even small monthly differences add up to substantial amounts. Here is how the three platforms compare on cost as of early 2026.

Medications Available

Both Hims and Ro primarily prescribe compounded semaglutide for weight loss. The active ingredient in compounded semaglutide is identical regardless of which platform prescribes it — the clinical efficacy comes from the medication itself, not the brand delivering it. Clinical trials have shown semaglutide produces average weight loss of 15 to 17 percent of body weight over 68 weeks.

Ro has been more proactive in offering compounded tirzepatide alongside semaglutide, giving patients an option for the dual GIP/GLP-1 receptor agonist that has shown even greater efficacy in clinical trials — up to 22.5 percent body weight reduction in the SURMOUNT-1 trial. Hims has offered tirzepatide more selectively, with availability depending on regulatory status and pharmacy partnerships at any given time.

Trimi offers both compounded semaglutide and compounded tirzepatide as core offerings, along with access to emerging treatments like retatrutide. Having both medications reliably available matters because many patients start with semaglutide and later transition to tirzepatide for enhanced results, or vice versa based on tolerability.

Provider Experience Compared

The provider experience differs meaningfully between these platforms. Hims relies primarily on asynchronous consultations — you fill out a health questionnaire and a provider reviews it without a live conversation. This approach is fast and convenient, but it limits the opportunity for clinical dialogue about your goals, concerns, or treatment adjustments.

Ro offers a more engaged clinical model with video consultations available for weight loss patients. This allows for real-time conversation with your provider, which can be particularly valuable during initial evaluation and when troubleshooting side effects or discussing dose changes. Ro providers also have access to metabolic lab data when patients opt for testing, giving them more clinical information to work with.

Both Hims and Ro, however, operate as broad-spectrum telehealth platforms where providers cover many health categories. Trimi's model centers on providers who focus specifically on weight management and metabolic health. This specialization means providers develop deeper expertise in GLP-1 dose titration, side effect management, and long-term weight maintenance strategies — the nuances that can meaningfully impact patient outcomes.

Delivery Speed and Pharmacy Quality

Delivery speed matters when you are eager to start treatment or running low on your current supply. Hims patients typically report initial delivery times of 7 to 14 days from completing their health assessment, which includes provider review, prescription processing, pharmacy compounding, and shipping. During periods of high demand, some patients have reported longer waits.

Ro generally delivers somewhat faster, with most patients receiving their medication within 5 to 10 days. Their pharmacy partnerships and fulfillment processes tend to be slightly more streamlined for weight loss medications specifically, likely due to the more focused investment in their Ro Body division.

Trimi targets delivery within 5 to 7 days of provider approval, with many patients receiving their first shipment in under a week. All three platforms partner with accredited compounding pharmacies that meet state and federal regulatory standards. The medication itself — compounded semaglutide or tirzepatide — is prepared to the same pharmaceutical standards regardless of which platform facilitates the prescription.

Who Should Choose Hims?

Who Should Choose Ro?

Why Trimi May Be the Better Option

For patients whose primary goal is effective, affordable GLP-1 weight loss treatment with quality medical support, Trimi addresses the key limitations of both Hims and Ro. At $99 per month for compounded semaglutide and $125 per month for compounded tirzepatide, Trimi's everyday pricing is lower than most Hims and Ro plans — even without promo codes or multi-month commitments.

Over a 12-month treatment course, choosing Trimi over Ro could save you $600 to $1,800. Compared to Hims, the savings may be smaller at the lowest Hims tier but Trimi offers a more predictable cost with no contract obligations and more specialized care. For a detailed breakdown of all affordable options, see our guide to the cheapest GLP-1 injections in 2026.

Bottom Line

Hims and Ro are both legitimate telehealth platforms delivering real GLP-1 medications prescribed by licensed providers. Hims wins on introductory pricing and platform breadth. Ro wins on clinical depth and provider engagement. But for patients focused specifically on getting effective GLP-1 weight loss treatment at the best possible price with dedicated support, Trimi offers a compelling case at $99 per month for semaglutide and $125 per month for tirzepatide — with no contracts, no hidden fees, and providers who specialize in weight management.

We recommend comparing current pricing directly on each platform before committing. Weight loss treatment is a long-term investment, and the monthly cost difference between providers compounds significantly over 6 to 12 months. The best provider is the one that delivers effective medication with quality support at a price you can sustain.